This study is currently not recruiting participants.

Long-Term Outcomes Protocol of Premature Infants Enrolled in the NICHD-2013-ABS01 (SCAMP) study

Antibiotic Treatments for GI Infections in Premature Infants

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

Evaluate the frequency of NDI and long-term GI outcomes in premature infants with cIAI after receiving different antibiotic treatment regimens that included ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, or gentamicin.

Detailed description of study

Evaluate the frequency of NDI and long-term GI outcomes in premature infants with cIAI after receiving different antibiotic treatment regimens that included ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, or gentamicin.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: premature infant
  • Age: 100 years or below
  • Gender: All

This study investigates the effects of different antibiotic treatments on premature infants with complicated intra-abdominal infections (cIAI). Complicated intra-abdominal infections are severe infections within the belly area that require medical treatment. The study aims to understand how these treatments affect the infants' neurodevelopmental impairment (NDI) and long-term gastrointestinal (GI) health outcomes.

Participants in this study will receive one of several antibiotic treatment regimens, which may include medications such as ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, or gentamicin. These antibiotics are used to treat infections by killing bacteria or stopping their growth. The study will observe how these treatments impact the infants' development and GI health over time.

  • Who can participate: The study is looking for premature infants born before 37 weeks of gestation who have been diagnosed with complicated intra-abdominal infections.
  • Study details: Participants will be assigned to receive one of the antibiotic treatment regimens. The study will monitor the effects of these treatments on the infants' health outcomes.
Updated on 19 Feb 2024. Study ID: 1709486842

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team